PharmaVOICE - 
May 2005
Purchase Issue

In Every Issue
On the Calendar
May 16-17 Global Clinical Trials Hyatt Regency Jersey City, Jersey [...]
By
PharmaTrax
Nano-Enabled Drug Discovery Market to Reach .3 Billion by 2009 [...]
By
Talent Pool
Pharma POOL Kevin Guthrie Thom Rowland Solvay Promotes VPs Solvay [...]
By
E-Media
Infotrieve Introduces New Search and Discovery Tool The LSRC employs [...]
By
What’s New
Society of Hospital Medicine Launches New Medical Journal The Society [...]
By
For Art’s Sake
For Art’s Sake Each month, this department pays homage to [...]
By
Letter from the Editor
Leadership is not magnetic personality — that can just as [...]
By

Taren Grom, Editor

PharmaOutlet
Lessons for Public Relations from the Presidential Trail Trina Chiara [...]
By

Trina Chiara

What’s on Your Mind — Opinions
Opinions More on Leadership Development PharmaVOICE received such an overwhelming [...]
By

On The Cover

Culture of Compliance: Cutting Through the Confusion
Culture of Compliance: Cutting Through the Confusion A few years after the Pharmaceutical Research and Manufacturers of America (PhRMA) code and the Office of the Inspector General (OIG) guidance, and the more recent implications of the Accreditation Council for Continuing Medical Education (ACCME) standards and FDA draft guidances regarding communication with healthcare providers, there is [...]
By

Elisabeth Pena Villarroel

Features

Diabetes: Novel Pipeline Compounds Offer New Hope
Tremendous progress has been made in the treatment of diabetes over the last decade. Still, many people with diabetes have poor glycemic control, and there is a need for more convenient therapies. As the prevalence of diabetes, especially type 2 diabetes, continues to increase, products in development offer new options. Joe Young In some regards, [...]
By

Lisa Dress

From Bar Codes to Chips & Antennas
Pharmaceutical companies are now testing the use of radio frequency identification (RFID) technologies, which hold the potential for protecting the patient, protecting the brand, and strengthening the supply chain. New applications of a not-so-new technology are about to completely change how the pharmaceutical supply chain is managed. Radio frequency identification (RFID) technologies will give current [...]
By

Denise Myshko

Shifting the Compliance Paradigm
VIEW on regulatory compliance Michael Kuehne is President of ACSYS Inc., Hillsborough, N.J., which specializes in developing quality and compliance solutions that combine R&D and manufacturing capabilities to deliver sustained improvement in R&D, Quality, Operations, Clinical, and Regulatory Affairs departments. This enhanced capability supports organizational capabilities to develop and launch new products and processes. Although [...]
By
Dr. Leo H. Sternbach — The Inventor’s Inventor
Eminent scientist Leo H. Sternbach, Ph.D., is being inducted into the National Inventors Hall of Fame nearly 42 years after his landmark invention Valium was approved by the FDA. PharmaVOICE is taking this opportunity to honor Dr. Sternbach, 97, for his extraordinary achievements. We would like to thank Roche, Dr. Sternbach’s son, Daniel Sternbach, Ph.D., [...]
By

Kim Ribbink

Complex Challenges: Strong Leaders
Today’s life-sciences industry is a complex, ever-evolving amalgamation of serious challenges to be met and surpassed. To forge ahead and succeed, the industry needs strong leaders who possess character, a commitment to public health, business acumen, and the willingness to mentor the next generation of healthcare professionals to address current and future challenges. The 2005 [...]
By

Taren Grom, Editor

The Art of the Deal
The biotech industry is in a much stronger position now than it was in its early days, and today biotech companies enjoy a prominent seat at the negotiation table. Biotech companies, especially those with products, are asking for true collaboration instead of relying on licensing deals. The days of biotech being the poor cousin of [...]
By

Denise Myshko

Table of Contents
On the Cover Culture of compliance: Cutting through the confusion To be compliant with the many regulations and guidances that apply to the marketing of prescription products, companies need to create a culture of compliance that fosters and promotes an ethical atmosphere and compliant behavior. 8 FEATURES The art of the deal The biotech industry [...]
By
FEEDBACK